Search Results - "S. Yerly"

Validation of a commercially available SARS-CoV-2 serological immunoassay by Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm-Vernez, I., Zimmer, G., Agoritsas, T., Stirnemann, J., Spechbach, H., Guessous, I., Stringhini, S., Pugin, J., Roux-Lombard, P., Fontao, L., Siegrist, C.-A., Eckerle, I., Vuilleumier, N., Kaiser, L.

“…To validate the diagnostic accuracy of a Euroimmun SARS-CoV-2 IgG and IgA immunoassay for COVID-19. In this unmatched (1:2) case-control validation study, we…”
Get full text

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV by Bick, Alexander G., Popadin, Konstantin, Thorball, Christian W., Uddin, Md Mesbah, Zanni, Markella V., Yu, Bing, Cavassini, Matthias, Rauch, Andri, Tarr, Philip, Schmid, Patrick, Bernasconi, Enos, Günthard, Huldrych F., Libby, Peter, Boerwinkle, Eric, McLaren, Paul J., Ballantyne, Christie M., Grinspoon, Steven, Natarajan, Pradeep, Fellay, Jacques

“…People living with human immunodeficiency virus (PLWH) have significantly increased risk for cardiovascular disease in part due to inflammation and immune…”
Get full text

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment by Pyngottu, Ashima, Scherrer, Alexandra U, Kouyos, Roger, Huber, Michael, Hirsch, Hans, Perreau, Matthieu, Yerly, Sabine, Calmy, Alexandra, Cavassini, Matthias, Stöckle, Marcel, Furrer, Hansjakob, Vernazza, Pietro, Bernasconi, Enos, Günthard, Huldrych F, Aebi-Popp, K, Anagnostopoulos, A, Battegay, M, Bernasconi, E, Böni, J, Braun, D L, Bucher, H C, Calmy, A, Cavassini, M, Ciuffi, A, Dollenmaier, G, Egger, M, Elzi, L, Fehr, J, Fellay, J, Furrer, H, Fux, C A, Günthard, H F, Haerry, D, Hasse, B, Hirsch, H H, Hoffmann, M, Hösli, I, Huber, M, Kahlert, C R, Kaiser, L, Keiser, O, Klimkait, T, Kouyos, R D, Kovari, H, Ledergerber, B, Martinetti, G, Martinez de Tejada, B, Marzolini, C, Metzner, K J, Müller, N, Nicca, D, Paioni, P, Pantaleo, G, Perreau, M, Rauch, A, Rudin, C, Scherrer, A U, Schmid, P, Speck, R, Stöckle, M, Tarr, P, Trkola, A, Vernazza, P, Wandeler, G, Weber, R, Yerly, S

“…Abstract Background Integrase strand transfer inhibitors (InSTIs) are recommended for first-line treatment of persons with human immunodeficiency virus (HIV)…”
Get full text

Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors? by Kletenkov, K, Hoffmann, D, Böni, J, Yerly, S, Aubert, V, Schöni-Affolter, F, Struck, D, Verheyen, J, Klimkait, T

“…HIV Gag mutations have been reported to confer PI drug resistance. However, clinical implications are still controversial and most current genotyping…”
Get full text

Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection by Hofmann, Eveline, Surial, Bernard, Boillat-Blanco, Noémie, Günthard, Huldrych F, Stöckle, Marcel, Bernasconi, Enos, Schmid, Patrick, Calmy, Alexandra, Suter-Riniker, Franziska, Rauch, Andri, Wandeler, Gilles, Béguelin, Charles

“…In the Swiss HIV Cohort Study, 61 of 222 (27%) HIV-suppressed persons with chronic hepatitis B virus (HBV) infection had HBV replication after 2 years on…”
Get full text

Triggers of Change in Sexual Behavior Among People With HIV: The Swiss U U Statement and COVID-19 Compared by Hamusonde, Kalongo, Nicca, Dunja, Gnthard, Huldrych F, Stckle, Marcel, Darling, Katharine E A, Calmy, Alexandra, Bernasconi, Enos, Haerry, David, Schmid, Patrick, Kouyos, Roger D, Rauch, Andri, Salazar-Vizcaya, Luisa

“…We assessed changes in sexual behavior among people with human immunodeficiency virus (HIV) over 20 years. Condom use with stable partners steadily declined…”
Get full text

Population pharmacokinetics of dolutegravir: influence of drug–drug interactions in a real-life setting by Barcelo, Catalina, Aouri, Manel, Courlet, Perrine, Guidi, Monia, Braun, Dominique L, Günthard, Huldrych F, Piso, Rein J, Cavassini, Matthias, Buclin, Thierry, Decosterd, Laurent A, Csajka, Chantal

“…Abstract Objectives Dolutegravir is widely prescribed owing to its potent antiviral activity, high genetic barrier and good tolerability. The aim of this study…”
Get full text

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men by Braun, Dominique L, Hampel, Benjamin, Kouyos, Roger, Nguyen, Huyen, Shah, Cyril, Flepp, Markus, Stöckle, Marcel, Conen, Anna, Béguelin, Charles, Künzler-Heule, Patrizia, Nicca, Dunja, Schmid, Patrick, Delaloye, Julie, Rougemont, Mathieu, Bernasconi, Enos, Rauch, Andri, Günthard, Huldrych F, Böni, Jürg, Fehr, Jan S

“…We treated 122 human immunodeficiency virus/hepatitis C virus-infected individuals with grazoprevir/elbasvir ± ribavirin for 12-16 weeks and achieved a…”
Get full text

Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity by Livio, Françoise, Deutschmann, Elisabeth, Moffa, Giusi, Rrustemi, Flamur, Stader, Felix, Elzi, Luigia, Braun, Dominique L, Calmy, Alexandra, Hachfeld, Anna, Cavassini, Matthias, Tarr, Philip E, Wissel, Kerstin, Battegay, Manuel, Marzolini, Catia

“…Abstract Background The extent of inappropriate prescribing observed in geriatric medicine has not been thoroughly evaluated in people ageing with HIV. We…”
Get full text

Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection by Carlisle, Louisa A, Turk, Teja, Kusejko, Katharina, Metzner, Karin J, Leemann, Christine, Schenkel, Corinne D, Bachmann, Nadine, Posada, Susana, Beerenwinkel, Niko, Böni, Jürg, Yerly, Sabine, Klimkait, Thomas, Perreau, Matthieu, Braun, Dominique L, Rauch, Andri, Calmy, Alexandra, Cavassini, Matthias, Battegay, Manuel, Vernazza, Pietro, Bernasconi, Enos, Günthard, Huldrych F, Kouyos, Roger D

“…Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and,…”
Get full text

Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study by Schwenke, Johannes M, Thorball, Christian W, Schoepf, Isabella C, Ryom, Lene, Hasse, Barbara, Lamy, Olivier, Calmy, Alexandra, Wandeler, Gilles, Marzolini, Catia, Kahlert, Christian R, Bernasconi, Enos, Kouyos, Roger D, Günthard, Huldrych F, Ledergerber, Bruno, Fellay, Jacques, Burkhalter, Felix, Tarr, Philip E

“…Abstract Background Bone mineral density (BMD) loss may be accelerated in people with HIV (PLWH). It is unknown whether a polygenic risk score (PRS) is…”
Get full text

Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study by Balakrishna, Suraj, Wolfensberger, Aline, Kachalov, Viacheslav, Roth, Jan A, Kusejko, Katharina, Scherrer, Alexandra U, Furrer, Hansjakob, Hauser, Christoph, Calmy, Alexandra, Cavassini, Matthias, Schmid, Patrick, Bernasconi, Enos, Battegay, Manuel, Günthard, Huldrych F, Kouyos, Roger D

“…Abstract Background Bacterial pneumonia is a leading reason for hospitalization among people with HIV (PWH); however, evidence regarding its drivers in the era…”
Get full text

Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach by Labarile, Marco, Loosli, Tom, Zeeb, Marius, Kusejko, Katharina, Huber, Michael, Hirsch, Hans H, Perreau, Matthieu, Ramette, Alban, Yerly, Sabine, Cavassini, Matthias, Battegay, Manuel, Rauch, Andri, Calmy, Alexandra, Notter, Julia, Bernasconi, Enos, Fux, Christoph, Günthard, Huldrych F, Pasin, Chloé, Kouyos, Roger D

“…Despite effective prevention approaches, ongoing human immunodeficiency virus 1 (HIV-1) transmission remains a public health concern indicating a need for…”
Get full text

A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study by Chaudron, Sandra E, Leemann, Christine, Kusejko, Katharina, Nguyen, Huyen, Tschumi, Nadine, Marzel, Alex, Huber, Michael, Böni, Jürg, Perreau, Matthieu, Klimkait, Thomas, Yerly, Sabine, Ramette, Alban, Hirsch, Hans H, Rauch, Andri, Calmy, Alexandra, Vernazza, Pietro, Bernasconi, Enos, Cavassini, Matthias, Metzner, Karin J, Kouyos, Roger D, Günthard, Huldrych F

“…Studying human immunodeficiency virus type 1 (HIV-1) superinfection is important to understand virus transmission, disease progression, and vaccine design. But…”
Get full text

Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study by Kovari, Helen, Calmy, Alexandra, Doco-Lecompte, Thanh, Nkoulou, René, Marzel, Alex, Weber, Rainer, Kaufmann, Philipp A, Buechel, Ronny R, Ledergerber, Bruno, Tarr, Philip E

“…Abstract Background Coronary artery disease (CAD) events have been associated with certain antiretroviral therapy (ART) agents. In contrast, the influence of…”
Get full text

Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study by Duran Ramirez, Jessy J, Ballouz, Tala, Nguyen, Huyen, Kusejko, Katharina, Chaudron, Sandra E, Huber, Michael, Hirsch, Hans H, Perreau, Matthieu, Ramette, Alban, Yerly, Sabine, Cavassini, Matthias, Stöckle, Marcel, Furrer, Hansjakob, Vernazza, Pietro, Bernasconi, Enos, Günthard, Huldrych F, Kouyos, Roger D

“…Abstract Background In Switzerland, HIV-1 transmission among men who have sex with men (MSM) has been dominated by subtype B, whilst non-B subtypes are…”
Get full text

Ageing with HIV: medication use and risk for potential drug-drug interactions by Marzolini, Catia, Back, David, Weber, Rainer, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Bernasconi, Enos, Khoo, Saye, Battegay, Manuel, Elzi, Luigia

“…Objectives To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the effect on antiretroviral therapy (ART) tolerability and…”
Get full text

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study by Assoumou, L, Charpentier, C, Recordon-Pinson, P, Grudé, M, Pallier, C, Morand-Joubert, L, Fafi-Kremer, S, Krivine, A, Montes, B, Ferré, V, Bouvier-Alias, M, Plantier, J-C, Izopet, J, Trabaud, M-A, Yerly, S, Dufayard, J, Alloui, C, Courdavault, L, Le Guillou-Guillemette, H, Maillard, A, Amiel, C, Vabret, A, Roussel, C, Vallet, S, Guinard, J, Mirand, A, Beby-Defaux, A, Barin, F, Allardet-Servent, A, Ait-Namane, R, Wirden, M, Delaugerre, C, Calvez, V, Chaix, M-L, Descamps, D, Reigadas, S

“…Surveillance of HIV-1 resistance in treated patients with a detectable viral load (VL) is important to monitor, in order to assess the risk of spread of…”
Get full text

Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores by Dietrich, Léna G, Thorball, Christian W, Ryom, Lene, Burkhalter, Felix, Hasse, Barbara, Thurnheer, Maria Christine, Weisser, Maja, Schmid, Patrick, Bernasconi, Enos, Darling, Kathrine E A, Buvelot, Hélène, Fellay, Jacques, Ledergerber, Bruno, Tarr, Philip E

“…In people with human immunodeficiency virus (PWH), it is unknown whether genetic background associates with rapid progression of kidney dysfunction (ie,…”
Get full text

Changing Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up Era by Salazar-Vizcaya, Luisa, Kouyos, Roger D, Metzner, Karin J, Caraballo Cortes, Kamila, Böni, Jürg, Shah, Cyril, Fehr, Jan, Braun, Dominique L, Bernasconi, Enos, Mbunkah, Herbert A, Hoffmann, Matthias, Labhardt, Niklaus, Cavassini, Matthias, Rougemont, Mathieu, Günthard, Huldrych F, Keiser, Olivia, Rauch, Andri

“…Abstract Background Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV) incidence among human immunodeficiency virus…”
Get full text